Intra-Arterial Tenecteplase After Thrombectomy: Promising but Inconclusive
Ashutosh Jadhav recently shared a post on further management of stroke after successful thrombectomy on X:
”Intra-arterial Tenecteplase for Acute Stroke After Successful Endovascular Therapy.”
Read the full JAMA article here.
A recent study evaluating intra-arterial tenecteplase administered after successful thrombectomy in patients with acute large vessel occlusion (LVO) presenting between 4.5 and 24 hours of symptom onset has shown encouraging yet inconclusive results.
Patients receiving intra-arterial tenecteplase demonstrated a greater likelihood of excellent neurological outcomes at 90 days, without an associated increase in symptomatic intracranial hemorrhage (sICH) or mortality.
However, the optimism was tempered by the fact that none of the secondary efficacy endpoints reinforced the primary findings.
The authors emphasized that further trials are necessary to validate these results and better define the role of intra-arterial tenecteplase in extended-window stroke management.
More on advancements in stroke management featured in Hemostasis Today.
-
Jan 7, 2026, 08:50Fahad Khaliq on When is Ticagrelor Preferred Over Other Antiplatelets
-
Jan 7, 2026, 06:41Zain Khalpey on AI Driven Risk Prediction for Optimization of Anticoagulation in LVAD
-
Jan 7, 2026, 05:47Michael Makris: The Wakley Prize Essay Published in Today’s Lancet is an Excellent Read
-
Jan 7, 2026, 05:36Pierre F Sabouret Shares A Study on the Risk of Cardiovascular Death in SIDs
-
Jan 7, 2026, 05:15Glaivy Batsuli Reflects on ASH25
-
Jan 7, 2026, 05:04Heghine Khachatryan on VWD: A Landmark in the History of Hematology
-
Jan 6, 2026, 13:39JAMA Neurology: No Added Benefit of Dual Therapy After Ischemic Stroke in Case of AFib
-
Jan 6, 2026, 10:10This is Fantastic: Shirley D’Sa on Transfusion-Free Christmas Milestone for 𝛃-Thalassaemia Patient at UCLH
-
Jan 6, 2026, 09:53Hamideh Yadegari: Coagulation–Inflammation Crosstalk: Mechanisms, Pathways, and Clinical Implications